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Notch1 signaling is required for T cell development
and has been implicated in fate decisions in the
thymus. We showed that Notch1 deletion in progen-
itor T cells (pro-T cells) revealed their latent develop-
mental potential toward becoming conventional and
plasmacytoid dendritic cells. In addition, Notch1
deletion in pro-T cells resulted in large numbers
of thymic B cells, previously explained by T-to-B
cell fate conversion. Single-cell genotyping showed,
however, that the majority of these thymic B cells
arose from Notch1-sufficient cells by a cell-extrinsic
pathway. Fate switching nevertheless exists for
a subset of thymic B cells originating from Notch1-
deleted pro-T cells. Chimeric mice lacking the Notch
ligand delta-like 4 (Dll4) in thymus epithelium revealed
an essential role for Dll4 in T cell development. Thus,
Notch1-Dll4 signaling fortifies T cell commitment by
suppressing non-T cell lineage potential in pro-T
cells, and normal Notch1-driven T cell development
repels excessive B cells in the thymus.
INTRODUCTION
The Notch signaling pathway guides cell-fate decisions in
multiple developmental processes (Artavanis-Tsakonas et al.,
1999; Dumortier et al., 2005). In hematopoiesis, Notch1 signaling
can influence the ‘‘balance’’ between T cell and B cell develop-
ment (Jenkinson et al., 2006; Maillard et al., 2005; Osborne,
2000; Radtke et al., 2004; Robey and Bluestone, 2004; Rothen-
berg et al., 2008; Tanigaki and Honjo, 2007). Overexpression or
constitutive activation of Notch1 signaling promotes T cell devel-
opment, blocks B cell development (Pui et al., 1999), and is
frequently associated with T cell leukemia (Aster et al., 2008).
In contrast, deletion of Notch1 or inhibition of Notch1 signaling
in hematopoietic stem cells (HSCs) blocks T cell development
in favor of unusually high numbers of thymic B cells (Izon et al.,
2002; Koch et al., 2001; Maillard et al., 2004; Radtke et al.,
1999; Wilson et al., 2001).The abundance of B cells in the thymus under conditions of
impaired Notch1 signaling has been interpreted as evidence
for cell-intrinsic fate switching of lymphoid or perhaps T cell-
committed progenitors toward becoming B cells. Such cell-
autonomous T-to-B cell conversion implies that Notch1-
expressing progenitors, destined to become T cells under
Notch1 signaling, transdifferentiate to become B cells in the
absence of Notch1 signaling. A less considered possibility is
that B cells appearing in the thymus under conditions of loss of
Notch1 function may not share a precursor-product relationship
with Notch1-deleted progenitors. Such B cells would be devel-
opmentally unrelated to the T cell pathway, and they might fill
available space in the thymus. Direct experimental evidence dis-
tinguishing between these possibilities is lacking (Maillard et al.,
2005). A question closely related to the plasticity of thymic
precursors is their potential for becoming dendritic cells (DCs)
(Shortman and Naik, 2007). It is interesting to consider an
involvement of Notch1 in progenitor T cell (pro-T cell)-to-DC
fate decisions in the thymus. Inactivation of Notch1 signaling
after the T-B cell bifurcation and prior to CD4CD8 double-
negative (DN) CD25+ stages in the thymus, when B cells can
no longer arise experimentally (Sambandam et al., 2005; Schmitt
et al., 2004), might provide a clue for these questions. However,
relevant pathways from the HSC up to the pro-T stage are largely
uncharted and hence difficult to manipulate in vivo (Benz et al.,
2008; Bhandoola et al., 2007; Petrie and Kincade, 2005; Rode-
wald, 1995).
We have generated a Cre-recombinase (Cre)-deleter mouse
that shows ‘‘T cell-biased’’ Cre activity. This strain permits pref-
erential deletion of floxed (fl) genes in the T cell pathway down-
stream of the physiological T-B cell bifurcation. Using the
ROSA26-RFP (RFP) reporter mouse expressing the tandem-
dimer red fluorescent protein (RFP) gene in a Cre-dependent
manner (Luche et al., 2007), we demonstrated RFP expression
in 45% of DN1 Kit+ T cell progenitors, and it was maximal
(90%) as of the DN2 stage. Disruption of Notch1 in pro-T cells
with this Cre line impaired T cell development and was associ-
ated with increased numbers of thymic B cells, as expected. In
conflict with the idea of fate conversion as the major, if not
only, mechanism underlying the generation of additional thymic
B cells under conditions of Notch1 deficiency, we found that
a large fraction of thymic B cells arose from non-Notch1-deletedImmunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc. 67
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Role of Notch1 and Delta-like 4 in the ThymusFigure 1. Experimental Setup and T Cell-Biased Cre-Labeling
Pattern in Cpa3Cre Mice
(A) Cpa3Cre mice were crossed with Cre-dependent ROSA26-RFP (RFP)
reporter mice. The RFP reporter locus harbors two pairs of loxP sites (repre-
sented by green and blue triangles) that are pairwise compatible. Permanent
RFP expression is achieved via Cre-dependent recombination steps involving
inversion of the RFP gene and deletion of the stopper (Luche et al., 2007).
(B) Spleen cells from Cpa3CreRFP and RFP control mice were stained for CD3
versus CD19 expression, and RFP expression was analyzed after gating on
CD3+ T cells and CD19+ B cells. Data are representative of seven independent
experiments.
(C) This T cell-biased Cre activity preferentially labels the T cell lineage down-
stream of the physiological T-B cell bifurcation (‘‘branch point’’). Frequencies
of RFP-markedcells inT cell andB cell development areschematically depicted.68 Immunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc.progenitors. Hence, these B cells are influenced cell-extrinsically
by loss of Notch1 in T cell progenitors. The second key finding
uncovered by deletion of Notch1 at the pro-T cell stage is
a Notch1-dependent, cell-intrinsic redirection of cells out of the
T cell pathway into thymic DCs of conventional and plasmacy-
toid lineages. These experiments expand the range of develop-
mental processes that are regulated by Notch1 via cell-intrinsic
and cell-extrinsic mechanisms in the thymus. Finally, we provide
genetic evidence that the Notch ligand delta-like 4 (Dll4) is crucial
for T cell development in vivo. Thus, we report a crucial function
of Notch1 in limiting development of pro-T cells toward DC and B
cell lineages in the thymus and reveal an unexpected capacity of
thymic niches, deserted by Notch1-deficient thymocytes, to host
B cells that do not arise in the T cell pathway.
RESULTS
Cpa3Cre Labels the Vast Majority of T Cells Downstream
of the T-B Cell Bifurcation
For quantifying hematopoietic pathways in vivo, mice expressing
Cre in lineage-restricted loci are useful for Cre-driven fate
mapping and for deletion of floxed genes (Rajewsky et al.,
1996). We constructed by gene targeting a knockin mouse in
which Cre expression is under the control of the Cpa3 gene
encoding mast cell carboxypeptidase A (Mc-cpa). Cpa3 is
considered a mast cell-specific gene (Reynolds et al., 1989)
and is expressed in this lineage from the progenitor stage
onward (Rodewald et al., 1996). To assess the labeling pattern
of Cre, we crossed Cpa3Cre mice with Cre-dependent RFP
reporter mice. In Cpa3CreRFP mice, all cells expressing Cre at
one point in ontogeny, as well as their progeny, were perma-
nently labeled by RFP (Figure 1A). A survey of hematopoietic line-
ages showed, interestingly, frequencies of RFP+ CD3+ T cells in
the spleen in the order of 90% (88% [mean] ± 5% [one standard
deviation]; n = 7 mice). Frequencies of RFP+ CD19+ splenic B cells
were, by comparison, very low (4.6% ± 2.0%; n = 7) (Figure 1B).
Differential marking of T cells and B cells was recapitulated by
transplantation of lymphocyte-depleted bone marrow cells from
Cpa3CreRFP into alymphoid Rag2/Il2rg hosts (data not
shown), demonstrating that the T-over-B cell bias was ongoing
in adult T cell and B cell development.
Preferential T cell labeling implied that Cre was predominantly
active downstream of the physiological split between T and B
cell lineages (Figure 1C). Next, we searched for the stage in
T cell development in which labeling first became apparent. In
CD4+CD8+ double-positive (DP) and CD4+CD8 and CD4CD8+
single-positive (SP) thymocyte subsets, frequencies of RFP+
cells were as high as in peripheral T cells (data not shown). Simi-
larly, 90% of DN2 (90.2% ± 2.7%; n = 4), DN3 (93.9% ± 1.5%;
(D) Subsets of DN cells, defined as Lin DN1 Kit+Flt3+, Lin DN1 Kit+, DN2,
DN3, and DN4, from Cpa3CreRFP and wild-type control mice were analyzed
for RFP expression. Mice were between 5 weeks and 3 months old, and the
RFP labeling pattern was age independent (data not shown). Data are repre-
sentative of at least three independent experiments.
(E) DN subsets were purified from normal mice by cell sorting and analyzed
by RT-PCR for endogenous expression of Cpa3 (top) and Actb (bottom).
The triangle represents 10-fold dilutions of the cDNAs. Data from one of two
independent experiments are shown.
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(Figure 1D). Interestingly, labeling was evident already in 25%
(22.4% ± 4.1%; n = 3) of the earliest pro-T cells, defined as
lineage-marker-negative (Lin) DN1 Kit+ Flt3+ (Sambandam
et al., 2005), and in 45% (46.2% ± 7.6%; n = 4) of the total
Lin DN1 Kit+ pro-T cell population (Figure 1D). Labeling was
saturated as of DN2 and remained high in subsequent stages.
BecauseCpa3 has been considered a mast cell-specific gene,
the very early and near-complete labeling of thymocytes was
unexpected and raised the question of whether expression of
Cpa3Cre paralleled expression of the endogenous Cpa3 locus
in the thymus. To this end, DN stages sorted from normal mice
were analyzed by reverse transcriptase-polymerase chain reac-
tion (RT-PCR). To exclude potential thymus-resident mast cells,
we included Fc3RI antibody in the Lin cocktail. The endogenous
Cpa3 gene was transcribed in DN1 Kit+, in DN2, and, to a lesser
extent, in DN3 and DN4, but not in CD19+Kit+ pro-B cells (Fig-
ure 1E). Mast cell genes, including Cpa3, are expressed in early
T cell progenitors (Taghon et al., 2007). According to our data, at
least 90% of all thymocytes pass through a Cpa3-expressing
stage. Frequencies of RFP+ cells among bone marrow stem cells
and progenitor populations are shown in Figure S1A (available
online), and they are further considered in the Supplemental
Results. Thus, Cpa3Cre mice label the earliest stages of T cell
development in the thymus and, possibly, in thymus-colonizing
progenitors, and they may hence be useful for genetically
manipulating pro-T cells in vivo.
Deletion of Notch1 by Cpa3Cre Impairs Pro-T Cell
Development
Deletion ofNotch1 in HSCs byMxCre blocked T cell development
and raised thymic B cell numbers (Radtke et al., 1999). In this
case, all progeny of Notch1-deleted HSCs, including B cells,
are Notch1 deleted. Ontogenetically later ablation of Notch1 by
LckCre perturbed thymocyte development without increasing
thymic B cells (Wolfer et al., 2002). Using Cpa3Cre, we addressed
consequences of Notch1 deletion en route from HSCs to T cells
and, importantly, downstream of the T-B cell split. To this end,
we generated Notch1fl/+Cpa3Cre and Notch1fl/flCpa3Cre mice.
Deletion of the floxed first exon of the Notch1 gene rendered
the mutant allele nonfunctional (Figure 2A) (Radtke et al.,
1999). If T cell development were impaired and thymic B cells
increased in Notch1fl/flCpa3Cre mice, the Notch1 genotype of
thymic B cells should be informative about the mechanism of
their generation.
Because Cre fate-mapped approximately 90%, but not all,
thymocytes (Figure 1), early T cell development was severely
diminished, but not fully arrested, in Notch1fl/flCpa3Cre mice.
Total thymocyte cellularity was reduced by 65% in Notch1fl/fl
Cpa3Cre mice (0.38 3 108 thymocytes) as compared to that in
Notch1fl/+Cpa3Cre mice (1.1 3 108 thymocytes) (Figure 2B).
Percentages of DP thymocytes were altered from 80% ± 4.6%
(n = 4) in Notch1fl/+Cpa3Cre mice to 65% ± 6.0% (n = 6) in
Notch1fl/flCpa3Cre mice, and SP stages were correspondingly
increased in Notch1fl/flCpa3Cre mice. The Notch1 dependency
of pro-T cell development (Sambandam et al., 2005; Tan et al.,
2005) was confirmed by the reduced percentages of DN1a
and DN1b cells (Porritt et al., 2004; also referred to as early
thymic progenitors [ETPs] in Bhandoola et al., 2003) inNotch1fl/flCpa3Cre mice (Figures 2C and 2D). Percentages of
DN CD25+ cells were reduced by more than 50% in Notch1fl/fl
Cpa3Cre mice (Figure 2E). Absolute numbers of DN1 Kit+, DN2
Kit+, and DN CD25+ cells were progressively diminished along
early thymocyte maturation (Figure 2F). Collectively, obstructed
DN development in Notch1fl/flCpa3Cre mice was consistent with
continuously required Notch1 signaling during T cell develop-
ment (Ciofani and Zuniga-Pflucker, 2007).
Deletion of Notch1 by Cpa3Cre Promotes Two B Cell
Populations in the Thymus
Because deletion of Notch1 at the HSC stage (Radtke et al.,
1999), but not at the DN2 and DN3 stages (Wolfer et al., 2002),
led to increased thymic B cell numbers, we next analyzed
whether deletion of Notch1 by Cpa3Cre resulted in the appear-
ance of more thymic B cells. Thymi from Notch1fl/+Cpa3Cre and
Notch1fl/flCpa3Cre mice were analyzed for percentages of
CD19- and B220-expressing B cells among DN cells. In the
Notch1fl/+Cpa3Cre control thymus, B cells were rare (Figure 3A,
left panel, and Figures 3D and 3E), and essentially all of these
were CD19hiB220hi cells (termed CD19hi). In contrast, in
Notch1fl/flCpa3Cre mice, percentages of thymic B cells were
increased approximately 10-fold (Figure 3A, right panel). These
B cells consisted of a major CD19hi population and an additional
CD19loB220lo (termed CD19lo) population. CD19lo and CD19hi B
cells were also found in the bone marrow (Figure 3B), where the
CD19 and B220 staining pattern was indistinguishable between
Notch1fl/+Cpa3Cre and Notch1fl/flCpa3Cre mice (data not shown).
CD19hi B cells from thymus and bone marrow of Notch1fl/+
Cpa3Cre and Notch1fl/flCpa3Cre mice had a mature B2 B cell
phenotype (Figure 3C). CD19lo thymic B cells, most of which
were IgM (Figure 3C), included pro-B cell (Kit+CD25) and
precursor B cell (pre-B cell; KitCD25+) phenotypes (Supple-
mental Results and Figure S2). Because percentages of thymic
B cells can be elevated because of the paucity of thymocytes
(Figure 2B), absolute numbers of total thymic B cells
(Figure 3D) and of CD19lo and CD19hi subsets (Figure 3E) were
compared in Notch1fl/+Cpa3Cre mice and Notch1fl/flCpa3Cre
mice. Total numbers of B cells varied over a wide range but
increased overall by 10-fold in Notch1fl/flCpa3Cre mice. Further
dissection revealed a larger absolute increment for CD19hi cells
than for CD19lo B cells (statistics summarized in the legend for
Figure 3). Collectively, consistent with deletion of Notch1 in
HSCs by MxCre, deletion of Notch1 in pro-T cells blocked early
T cell development and was associated with the new appear-
ance of CD19lo B cells in the thymus. Unexpectedly, however,
absolute numbers of both CD19lo and CD19hi B thymic cells
increased substantially.
Cell-Intrinsic and Cell-Extrinsic Notch1-Dependent
Mechanisms Leading to Thymic B Cells
If thymic B cells are generated by fate conversion from Notch1-
deleted progenitors, they must be homozygous Notch1 deleted.
To obtain genotype frequencies, we established a single-cell
PCR assay (see Supplemental Results for efficiency and speci-
ficity) that can distinguish homozygous floxed (Notch1fl/fl),
homozygous deleted (Notch1D/D), and heterozygous (Notch1fl/D)
genotypes. The Notch1 genotype was analyzed in 319 single
CD19lo and 272 single CD19hi thymic B cells from Notch1fl/flImmunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc. 69
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thymic B cells had a fundamentally different Notch1 genotype.
Out of all CD19lo B cells, 94% ± 5% were Notch1D/D (Figure 4B,
lower panel, and Figure 4C). This frequency was similar to the
deletion frequency in DN1 Kit+Flt3+ cells (87% Notch1D/D in
a total of 106 cells analyzed at the single-cell level in two inde-
pendent experiments). Quantitative deletion of Notch1 specifi-
cally in CD19lo B cells, but not in other B cells (see below),
showed that these B cells arose from Notch1-deleted progeni-
tors. This is consistent with a model of cell-intrinsic T-to-B cell
fate conversion.
In marked contrast, the frequency of homozygous Notch1
deletion in CD19hi thymic B cells was only 26% ± 11%
(Figure 4B, upper panel, and Figure 4C). Thus, the majority of
this major B cell population was not Notch1 deleted. Of note,
this deletion frequency in CD19hi thymic B cells was similar to
that measured for CD19lo (28% ± 10%) and CD19hi (19% ±
12%) B cells isolated from the bone marrow (Figure 4C), and it
was also in the range of the deletion frequency in common
lymphoid progenitors (CLPs) (Lininterleukin-7-receptor+Kitlo
Scalo) in the bone marrow. In a total of 110 CLPs analyzed at
the single-cell level in two independent experiments, 13%
were Notch1D/D. These data demonstrate that the majority of
cells from these three B cell populations (CD19hi thymic B cells,
CD19lo bone marrow B cells, and CD19hi bone marrow B cells)
develop independently of cell-intrinsicNotch1 deletion. Because
Figure 2. Impact of Notch1 Deletion by
Cpa3Cre on T Cell Development
(A) Schematic outline of exon 1 (Ex1) and Ex2 of
the Notch1 locus, the positions of the loxP sites
(triangle) in the Notch1fl allele, and the binding
sites of the oligonucleotides used for Notch1
genotyping. The configurations of the functional
nondeletedNotch1fl and the nonfunctional deleted
Notch1D alleles are depicted. The ordered use of
the oligonucleotides (1–4) for PCR genotyping is
described in the Supplemental Data.
(B) Absolute numbers of thymocytes were deter-
mined for Notch1fl/+Cpa3Cre (abbreviated Nfl/+)
mice (n = 10; 1.1 ± 0.5 3 108 thymocytes) and
for Notch1fl/flCpa3Cre (abbreviated Nfl/fl) mice (n =
24; 0.38 ± 0.25 3 108 thymocytes) (p < 0.05).
(C) LinCD44+CD25 thymocytes from Notch1fl/+
Cpa3Cre and Notch1fl/flCpa3Cre mice were
resolved into DN1a+b (HSA+Kit+) and DN1c
(HSAhiKitlo). Representative plots are shown.
(D) DN1a+b (represented by closed circles) and
DN1c (represented by open circles) are shown in
percent of total DN1 for Notch1fl/+Cpa3Cre and
Notch1fl/flCpa3Cre thymi. The bar indicates the
means for each cell population, and each circle
represents an individual thymus.
(E) Lin DN thymocytes from Notch1fl/+Cpa3Cre
and Notch1fl/flCpa3Cre mice were analyzed for
CD44 and CD25 expression. DN percentages in
Notch1fl/+Cpa3Cre mice (n = 5) were 4.5% ±
2.1% in DN1, 3.5% ± 0.8% in DN2, 48.0% ±
5.7% in DN3, and 44.1% ± 3.7% in DN4. DN
percentages in Notch1fl/flCpa3Cre mice (n = 11)
were 21.8% ± 8.7% in DN1, 3.0% ± 1.4% in
DN2, 20.8% ± 5.8% in DN3, and 54.6% ± 7.6%
in DN4. Representative plots are shown.
(F) Absolute cell numbers per Notch1fl/+Cpa3Cre
(abbreviated Nfl/+) thymus (represented by closed
circles) or per Notch1fl/flCpa3Cre (abbreviated
Nfl/fl) thymus (represented by open circles) were
determined for total DN1 Kit+ cells (1.34 ± 0.61 3
104 [n = 4] in Notch1fl/+Cpa3Cre versus 0.47 ±
0.38 3 104 [n = 8] in Notch1fl/flCpa3Cre [p <
0.05]), for Kit+ DN2 cells (1.80 ± 0.61 3 104 [n =
4] for Notch1fl/+Cpa3Cre versus 0.25 ± 0.30 3 104
[n = 8] in Notch1fl/flCpa3Cre [p < 0.05]), and for
CD25+ (DN2+DN3) cells (9.7 ± 3.2 3 105 [n = 6]
for Notch1fl/+Cpa3Cre versus 0.97 ± 0.99 3 105
[n = 10] in Notch1fl/flCpa3Cre [p < 0.05]). All mice
were 6 weeks old. The bar indicates the mean for
each cell population, and each circle represents
an individual thymus.70 Immunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc.
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CD19hi thymic B cell compartment in Notch1fl/flCpa3Cre mice
(Figure 3E), most thymic B cells arising in response to Notch1
deletion in the T cell pathway were not products of T-to-B cell
fate conversion. We refer to this as the cell-extrinsic pathway
of thymic B cells. Collectively, single-cell genotyping identified
Notch1-dependent cell-intrinsic and Notch1-dependent cell-
extrinsic mechanisms leading to the generation of thymic B cells.
Thymic B Cells Can Arise from
TCR-Rearrangement-Bearing Progenitors
To search for additional evidence that thymic B cells can origi-
nate from pro-T cells in vivo, we analyzed B cells from thymus
(Figures S3A, S3B, and S4A) and bone marrow (Figures S3C,
Figure 3. Deletion of Notch1 by Cpa3Cre
Promotes Thymic B Cell Populations
(A) CD4CD8 cells from Notch1fl/+Cpa3Cre and
Notch1fl/flCpa3Cre thymi were stained for CD19
versus B220. Percentages of CD19loB220lo
(termed CD19lo) and of CD19hiB220hi (termed
CD19hi) B cells are shown.
(B) For comparison, CD4CD8 cells from
Notch1fl/flCpa3Cre bone marrow were stained for
CD19 versus B220.
(C) B cells from Notch1fl/+Cpa3Cre thymi (left
column), Notch1fl/flCpa3Cre thymi (middle column),
or Notch1fl/flCpa3Cre bone marrow (right column)
were analyzed for expression of the indicated
cell-surface markers. Open histograms corre-
spond to CD19hi cells from Notch1fl/+Cpa3Cre
or Notch1fl/flCpa3Cre mice, and filled histograms
correspond to CD19lo cells from Notch1fl/fl
Cpa3Cre mice. CD19lo cells fromNotch1fl/+Cpa3Cre
do not present a defined population and are there-
fore not shown in the histograms.
(D) Absolute numbers of thymic B cells (CD19lo
plus CD19hi) were 6.9 ± 7.4 3 104 for Notch1fl/+
Cpa3Cre (n = 10) and 56 ± 68 3 104 Notch1fl/fl
Cpa3Cre (n = 24) mice (p < 0.05).
(E) Absolute numbers of CD19lo B cells per thymus
were 1.4 ± 2.0 3 104 Notch1fl/+Cpa3Cre (black
bars) versus 9.0 ± 12.8 3 104 Notch1fl/flCpa3Cre
(white bars) (p < 0.05), and absolute numbers of
CD19hi B cells per thymus were 5.6 ± 5.5 3 104
Notch1fl/+Cpa3Cre (black bars) versus 46.9 ±
60.6 3 104 Notch1fl/flCpa3Cre (white bars) (p <
0.05). Error bars show standard error of the
mean (SEM). Mice were 6 to 10 weeks old with
genotypes age matched (A–C). In (D) and (F),
Notch1fl/+Cpa3Cre were analyzed at 5, 8, and
9 weeks of age, and Notch1fl/flCpa3Cre were
analyzed at 5, 7, 8, 9, and 10 weeks of age. Data
in (A), (B), (D), and (E) are representative of at least
10 mice of each genotype, and data in (C) were
collected in four individual experiments.
S3D, and S4B) of Notch1fl/flCpa3Cre mice
for T cell receptor (TCR) b chain rear-
rangements. Essentially no TCR rear-
rangements were detectable in B cells
from the bone marrow (Figures S3C,
S3D, and S4B). In contrast, TCR Db1Jb1
rearrangements, but not Db2Jb2 rearrangements, were present
in DNA from CD19lo thymic B cells in Notch1fl/flCpa3Cre mice
(Figures S3A and S4A). A defined and isolatable population of
CD19lo B cells was only present in Notch1fl/flCpa3Cre mice,
but not in Notch1fl/+Cpa3Cre (Figure 3A) or wild-type (data not
shown)mice,precluding TCR-rearrangement analysesof acorre-
sponding population in a Notch-competent thymus. TCR rear-
rangements in CD19lo B cells from Notch1fl/flCpa3Cre mice,
together with the high frequency of Notch1D/D in these cells
(Figure 4C), showed that some CD19lo cells can develop from
Notch1-deleted pro-T cells bearing Db1Jb1 rearrangements.
Lack of Db2Jb2 rearrangements indicates that this diversion
can only happen prior to the DN2 stage (see Supplemental
Results).Immunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc. 71
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Role of Notch1 and Delta-like 4 in the ThymusFigure 4. Single-Cell Genotyping of CD19lo
and CD19hi Thymic B Cells
(A) CD4CD8 cells from Notch1fl/flCpa3Cre mice
were gated into CD19hi and CD19lo thymic B cells
according to the regions shown and were depos-
ited by single-cell sorting into PCR plates.
(B) The Notch1 genotype of single CD19hi B cells
(upper panel) and CD19lo B cells (lower panel)
was examined by nested PCR with the oligonucle-
otides shown in Figure 2A. Lower band, upper
band, and lower plus upper band correspond to
Notch1fl/fl, Notch1D/D, and Notch1fl/D genotypes,
respectively.
(C) In Notch1fl/flCpa3Cre mice, frequencies of
Notch1D/D genotypes (in percent of all cells
analyzed) are summarized for CD19lo versus
CD19hi B cells in the thymus and for CD19lo versus
CD19hi B cells in the bone marrow. Each symbol
corresponds to the single-cell PCR analysis of
one mouse, and the bar indicates the mean of
the frequencies for each group of mice. Total
numbers of B cells analyzed in all experiments
were 319 CD19lo and 272 CD19hi for the thymus
and 291 CD19lo and 293 CD19hi for the bone
marrow. Mice were 7–10 weeks old.Db1Jb1 rearrangements were found only very rarely in CD19hi
thymic B cells from Notch1fl/flCpa3Cre mice (Figures S3A and
S4A) and from wild-type mice (Figure S5). Rare TCR rearrange-
ments, together with the low frequencies of Notch1D/D in
CD19hi cells (Figure 4C), support the overall T cell-independent
origin of CD19hi B cells. Although we cannot exclude that
some B cells can progress from CD19lo to CD19hi stages in
Notch1fl/flCpa3Cre mice, such transition appeared to be rare
(Figures S3A and S4A). Hence, in the absence of Notch1
signaling, thymic B cells can arise from TCR rearrangement-
bearing progenitors, an event that apparently happens only
rarely in a normal thymus and never in the bone marrow.
T Cell-Biased Deletion of Notch1 Diverts Pro-T cells
to DCs in the Thymus
On the basis of the substantial potential of the DN1 Kit+ popula-
tion for DCs, it has been proposed that thymic DCs and T cells
share a common progenitor (Shortman and Naik, 2007). Given
that thymic DCs can develop independently of pro-T cells (Di
Santo et al., 2000), it remains to be determined to what extent
T cells and DCs develop from a common thymic pathway
in vivo and whether Notch1 signaling can influence the lineage
choice between the T cell and DC fates. We took advantage of
our Cre line to investigate the impact of Notch1 deletion on
potential pro-T cell-to-DC fate switching in the thymus.
Notch1fl/+Cpa3Cre and Notch1fl/flCpa3Cre mice were bred to
additionally harbor the RFP indicator locus. In control Notch1fl/+
Cpa3CreRFP mice, Cre can turn on RFP, but it cannot inactivate
Notch1. In these mice, RFP-labeling frequencies of thymic DC
populations should be informative about the originating progen-
itors when compared to labeling frequencies of DN subsets
(Figure 1D). In Notch1fl/flCpa3CreRFP mice, Cre expression can72 Immunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc.delete Notch1 while turning on RFP. If deletion of Notch1 drives
pro-T cell-to-DC fate conversion in the thymus, percentages of
RFP+ DCs should increase in Notch1fl/flCpa3CreRFP mice
compared to those in Notch1fl/+Cpa3CreRFP mice.
Thymic and splenic (Figure 5A) and bone marrow (Figure S1B)
DC subpopulations were separated into ‘‘lymphoid’’ DCs
(lyDCs), ‘‘myeloid’’ DCs (mDCs), and plasmacytoid DCs (pDCs)
(see Supplemental Data for phenotypes) and analyzed for RFP
expression (Figures 5B and 5C). In the Notch1fl/+Cpa3CreRFP
control thymus, 32%, 34%, and 20% of lyDCs, mDCs, and
pDCs, respectively, were RFP+ (Figure 5B), and similar frequen-
cies were found in the spleen (Figure 5B) and bone marrow
(Figure S1B). In the latter site, lyDCs were undetectable. For
the thymus, this fate-mapping result is compatible with an origin
of most thymic DCs from DN1 Kit+ Flt3+ cells, but not from cells
of later stages.
Interestingly, frequencies of RFP+ DCs increased in the
thymus (Figures 5B and 5C), but not the spleen (Figures 5B
and 5C) or bone marrow (data not shown) in Notch1fl/flCpa3Cre
RFP mice as compared to those in Notch1fl/+Cpa3CreRFP.
RFP-labeled DCs went up from 32% to 61% for lyDCs, from
34% to 56% for mDCs, and from 20% to 32% for pDCs
(Figure 5B). A similar increment was consistently observed for
each thymic DC population in all experiments (n = 7) (Figure 5C).
These changes in RFP-labeling frequencies correlated with
differences in Notch1 deletion frequencies. In thymic DCs of
Notch1fl/flCpa3CreRFP mice, frequencies of Notch1D/D were
85% (74 cells analyzed) for lyDCs, 69% (80 cells) for mDCs,
and 75% (77 cells) for pDCs. In splenic DCs, frequencies
of Notch1D/D were 54% (71 cells) for lyDCs, 32% (66 cells)
for mDCs, and 20% (75 cells) for pDCs. Hence, both
Notch1 deletion and RFP expression were consistent with
Immunity
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In further support of a pro-T origin of some thymic DCs, TCR
Db1Jb1 rearrangements were detectable in DNA from lyDCs
and pDCs, but not from mDCs, from the thymus of Notch1fl/fl
Cpa3CreRFP mice (Figure S6). Such TCR rearrangements were
absent from DC populations in the spleen of Notch1fl/fl
Cpa3CreRFP mice (Figure S6) and, in agreement with earlier
reports (Shortman and Naik, 2007), also from DCs in the wild-
type thymus (Figure S7).
On the basis of this combination of Notch1 deletion with fate
mapping, we propose that most thymic DCs normally either orig-
inate independently of the T cell pathway or branch off no later
than at the DN1 Kit+ Flt3+ pro-T stage. In contrast, under condi-
tions of blocked Notch1 signaling in pro-T cells, a substantial
proportion of thymic DCs can arise by pro-T cell-to-DC fate
conversion. Because absolute numbers of thymic DC subsets
were similar when we compared Notch1fl/+Cpa3CreRFP with
Notch1fl/flCpa3CreRFP mice (data not shown), the size of thymic
DC compartments appears to be regulated by mechanisms
other than DC production.
Notch Ligand Delta-like 4-Deficient Thymus
Epithelium Fails to Support T Cell Development
Notch1 is crucial for T cell development in vivo, but it is unknown
which Notch ligand(s), expressed by thymus epithelial cells
(TECs), are important for Notch1 signaling in the thymus. Several
Notch and Notch ligand family members are expressed in T cell
progenitors and in TECs, respectively. However, not every
possible pair of Notch-Notch ligand appears to be functionally
equivalent. In vitro, Dll1 can induce T cell development via Notch1
or Notch2, whereas Dll4 promotes T cell commitment only via
Notch1.Hence, although Notch1 can receive T lineage-promoting
signals via either Dll1 or Dll4 in vitro (Besseyrias et al., 2007), the
thymic Notch ligand relevant in vivo remains unknown. We
addressed this question by using nude (Foxn1nu/nu) blastocyst
complementation that can target homozygous null mutations to
medullary and cortical TECs in vivo (Muller et al., 2005). This
genetic assay is based on the fact that Foxn1nu/nu TECs have
a cell-intrinsic defect that cannot be rescued by the presence of
Foxn1+/+ TECs (Rodewald, 2008). In a first set of experiments,
we generated Dll1LacZ/LacZ embryonic stem (ES) cells /
Foxn1nu/nu blastocyst chimeras.Dll1LacZ encodes a nonfunctional
allele (Hrabe de Angelis et al., 1997) that can visualize
Dll1-expressing cells and that abrogates Dll1 expression in the
homozygous state (Dll1LacZ/LacZ, termed Dll1/). In Dll1/ /
Foxn1nu/nu chimeras, Dll1 expression was overall restricted to
thymus blood vessels (not shown). Thymus structure and T cell
development were completely unaffected by the absence of
Dll1 in TECs. Moreover, grafting of the third pouch region, the
tissue that hosts the thymus anlage, from day 10.5 Dll1/ mice
(Hrabe de Angelis et al., 1997) into nude mice yielded functional
thymus (data not shown). We, therefore, exclude a nonredundant
role of Dll1 in thymus organogenesis or T cell development. In
a second set of experiments, we used a Dll4LacZ knockin reporter
allele (Gale et al., 2004) to identify expression and function of Dll4
in the thymus, again using nude complementation (Figure 6A). The
Dll4LacZ allele is nonfunctional (Gale et al., 2004). In contrast to
when we generated chimeric mice by using Dll1/ ES cells, we
could not derive surviving pups after injection of Dll4LacZ/LacZ(termed Dll4/) ES cells/ Foxn1nu/nu blastocyst (see Discus-
sion). We next focused our search for informative chimeras on
the period between fetal day 18.5 and birth, and we succeeded
in identifying two mice (one from day 18.5 and one newborn) in
which thymus development beyond the ‘‘nude block’’ was
apparent. Two thymi from Dll4/ ES cells/ Foxn1nu/nu blasto-
cyst chimeras (termed Dll4/ thymi) were analyzed in detail by
immunofluorescence, and both yielded similar results (shown in
Figure 6 for the newborn thymus). Unlike the cystic, noncomple-
mented Foxn1nu/nu thymus (Figure 6E), the Dll4/ thymus pre-
sented as a three-dimensional structure made of cytokeratin+
major histocompatibility complex (MHC) class II+ TECs (Fig-
ure 6D). The entire thymus, but not its surrounding cytokeratin
nonthymic tissue, was strongly LacZ+ (Figure 6B). In contrast to
that in the age-matched control thymus (Figure 6C), T cell devel-
opment was undetectable in the neonatal Dll4/ thymus
(Figure 6D). CD4+CD8+ thymocytes were lacking, but B220+ B
cells were likewise not present in large numbers in the neonatal
Dll4/ thymus (Figure 6D). These data suggest that expression
of the Notch1 ligand Dll4 in TECs is essential for T cell develop-
ment in vivo.
DISCUSSION
For shedding light on the role of Notch1 signaling in develop-
mental fate decisions of pro-T cells in the thymus, it was neces-
sary to couple Notch1 deletion to the T cell pathway in vivo. We
generated a new Cre knockin mutant that fortuitously showed
a T cell-biased expression pattern reflecting the endogenous
Cpa3 expression in pro-T cells. Cpa3 transcription can be regu-
lated by GATA factors (Zon et al., 1991). A possible cascade of
events could be that Notch1 signaling in pro-T cells induces
GATA3 expression (Rothenberg, 2007), which, in turn, leads to
Cpa3Cre expression. Next, Cre deletes Notch1, setting the stage
to reveal non-T cell fates of pro-T cells in their natural environ-
ment in vivo.
We used this system to combine fate mapping with conditional
Notch1 deletion, which revealed Notch1-dependent cell-
intrinsic T cell-to-DC conversion in the thymus. Pro-T cells
have DC potential in vitro and in adoptive-transfer experiments
in vivo (Shortman and Naik, 2007), and other myeloid lineages
can also be generated from thymic precursors at high frequen-
cies in vitro (Balciunaite et al., 2005; Bell and Bhandoola, 2008;
Wada et al., 2008). Moreover, latent myeloid potential in
committed T cell progenitors has been elicited by ectopic cyto-
kine signals (King et al., 2002) and by deregulation of transcrip-
tion factors (Laiosa et al., 2006; Rothenberg, 2007), and it can
be influenced by Notch signaling in human T cell progenitors
in vitro (Dontje et al., 2006). However, it remains to be clarified
to what extend, if at all, substantial numbers of thymic myeloid
cells, including DCs, originate from pro-T cells in vivo. Interest-
ingly, it has been proposed that Notch-Delta signaling puts
a natural restraint on the latent myeloid potential of pro-T cells
in the thymus (Laiosa et al., 2006; Rothenberg, 2007). Our exper-
iments fully supported this idea. Under conditions permissive for
Notch1 signaling, frequencies of RFP+ DCs were, for all DC
subsets, lower than frequencies of RFP+ DN1 Kit+ cells and
much lower than frequencies of RFP+ DN2 cells. Accordingly,
the majority of thymic DCs cannot branch off later than at theImmunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc. 73
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Role of Notch1 and Delta-like 4 in the ThymusFigure 5. Combining Notch1 Deletion with Fate Mapping Reveals Pro-T cell-to-DC Diversion in the Thymus
(A) Phenotype of analyzed thymic and splenic dendritic cell populations. DC subpopulations were gated into MHC class IIhiB220CD11c+CD11b (lymphoid DCs,
lyDC) or MHC class IIhiB220CD11c+CD11b+ (myeloid DCs, mDC), or MHC class IIloB220+CD11c+CD11b (plasmacytoid DCs, pDC). Data shown are from
a Notch1fl/+Cpa3CreRFP mouse, but the same DC phenotypes and distributions were seen in Notch1fl/fl Cpa3CreRFP mice. Plots are a representative example
of the mice analyzed in (C).
(B) DC populations from thymus and spleen of Notch1fl/+Cpa3CreRFP and Notch1fl/fl Cpa3CreRFP mice were gated as shown in (A) and analyzed for percentages
of RFP-expressing cells. Histograms are representative examples for the mice summarized in (C).74 Immunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc.
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Role of Notch1 and Delta-like 4 in the ThymusDN1 Kit+Flt3+ stage, or they normally develop independently of
pro-T cells in vivo. The latter model would be in keeping with
pro-T cell-independent thymic DC development (Di Santo
et al., 2000). However, upon Notch1 deletion in pro-T cells,
RFP-labeling frequencies approximately doubled. Moreover, in
Notch1fl/flCpa3CreRFP mice, frequencies of Notch1D/D were
higher for thymic DCs than for splenic DCs, and TCR rearrange-
ments were found in thymic DC subpopulations from Notch1fl/fl
Cpa3CreRFP mice, but not from wild-type mice. Together, these
results point at Notch1-dependent T cell-to-DC fate conversion
within the thymus. Notably, all analyzed DC subtypes, earlier
classified as lymphoid, myeloid, and plasmacytoid DCs, were
included in this transdifferentiation process. Of these, only lyDCs
and pDCs showed signs of TCR rearrangements. This is consis-
tent with the proposal that these two lineages are close to
a lymphoid origin (Shortman and Naik, 2007). According to our
Figure 6. Analysis of the Role of Dll4 in
Thymus Epithelium by Nude Complementa-
tion
(A) Experimental outline for targeting Dll4 defi-
ciency into thymus epithelium in vivo. After injec-
tion of Dll4/ ES cells into Foxn1nu/nu blastocysts,
thymus epithelium in chimeric mice is exclusively
of ES cell origin, not of blastocyst origin.
(B) May-Gru¨nwald-Giemsa staining of the thymus
in a newborn Dll4/ into Foxn1nu/nu chimera
(termed Dll4/ thymus) and LacZ staining of the
serial sections of the same thymus. Note the
blue thymus and white surrounding nonthymic
tissue, probably fat.
(C–E) Immunofluorescence analysis of structure
and function of wild-type thymus (C), Dll4/
thymus (D), and Foxn1nu/nu thymus (transversal
section with bilateral thymus anlage, trachea,
and esophagus) (E). All thymi are from newborn
mice. Thymus sections (5 mm) were stained for
pan-cytokeratin versus MHC class II and for CD4
versus CD8 or for Thy1 versus B220. The scale
bar in (B) applies to all panels and corresponds
to 200 mm. Data shown are from one out of two
independent experiments, both showing lack of
T cell development in the absence of Dll4 in TECs.
fate mapping, mDCs should now be
included in the non-T cell potential of
pro-T cells. The efficiency of pro-T cell-
to-DC conversion is unknown, and it
may be an infrequent event in a wild-
type thymus. However, a large fraction
of thymic DCs can originate from pro-T
cells in vivo upon withdrawal of Notch1
signals.
Conclusions on the origins of thymic B cells under conditions
of Notch1 deficiency in the hematopoietic system must consider
the specificity of Notch1 targeting. Genetic inhibition of Notch1
signaling in hematopoietic cells in vivo has previously been
achieved by, among other approaches, conditional ablation of
Notch1 (Radtke et al., 1999; Wilson et al., 2001; Wolfer et al.,
2001), dysglycosylation of Notch1 via transgenic overexpression
of lunatic fringe (Lfng) (Koch et al., 2001), deletion of the tran-
scription factor recombination signal-binding protein-J (RBP-J)
(Han et al., 2002), overexpression of the Notch modulator Del-
tex1 (Izon et al., 2002), or interference with the transcriptional
activity of Notch1 using dominant-negative mastermind-like
protein 1 (Maillard et al., 2004). In cases of global deletion in
bone marrow cells (e.g., Izon et al., 2002; Maillard et al., 2004;
Radtke et al., 1999; Wilson et al., 2001), loss of Notch1 may
have affected the developmental potential of HSCs, CLPs,(C) Summary of frequencies of RFP+ lyDCs, mDCs, and pDCs in thymi of Notch1fl/+Cpa3CreRFP mice (abbreviated Nfl/+; represented by closed circles) and
Notch1fl/flCpa3CreRFP mice (abbreviated Nfl/fl; represented by open circles) and in the spleens of Notch1fl/+Cpa3CreRFP mice (abbreviated Nfl/+; represented
by closed triangles) and Notch1fl/flCpa3CreRFP mice (abbreviated Nfl/fl; represented by open triangles). In the thymi, frequencies of RFP+ cells for lyDCs, were
31.5% ± 3.9% (n = 7) in Nfl/+ mice and 65.5% ± 6.8% (n = 7) in Nfl/fl mice (p < 0.05); for mDCs, 38.1% ± 6.4% (n = 7) in Nfl/+ mice and 51.9% ± 5.8% (n = 7)
in Nfl/fl mice (p < 0.05); and for pDCs, 19.2% ± 4.2% (n = 7) in Nfl/+ mice and 48.5% ± 11.9% (n = 6) in Nfl/fl mice (p < 0.05). For the spleens, frequencies of
RFP+ cells were also determined for lyDCs (29.8% ± 5.4% in Nfl/+ [n = 7] versus 31.6% ± 7.5% in Nfl/fl [n = 7] [p = 0.40; not significant]), for mDCs (30.3% ±
6.1% in Nfl/+ [n = 7] versus 32.3% ± 7.1% in Nfl/fl [n = 7] [p = 0.27; not significant]), and for pDCs (17.7% ± 5.2% in Nfl/+ [n = 7] versus 19.8% ± 7.1% in Nfl/fl
[n = 7] [p = 0.27; not significant]).Immunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc. 75
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Notch1 inside the thymus using LckCre (deletion completed by
DN3) caused specific defects in T cell development but was
possibly too late for a T-to-B cell switch (Wolfer et al., 2002).
Several conclusions emerge from these earlier studies: The
first is that, in all cases of an early block in T cell development,
thymic B cells appeared in increased numbers. Second, deletion
of Notch1, or interference with Notch1 function, was not
restricted to the T cell pathway, and the resulting phenotype
may have been due to altered development of some or several
of these populations. Third, by definition, all progeny of
Notch1-deleted HSCs are also lacking Notch1; hence, all B cells
are Notch1 deleted, regardless of whether they developed in the
bone marrow or in the thymus and whether this deletion was the
underlying mechanism for their appearance in the thymus.
Fourth, frequencies of B cell potential in DN1 Kit+ cells, read
out in the absence of Notch signals, are very low, ranging from
1/30 (Heinzel et al., 2007) to 1/500 (Sambandam et al., 2005) or
even less (Balciunaite et al., 2005). In summary, it remained
ambiguous whether B cells arising under conditions of impaired
Notch1 signaling were, in fact, fate-converted descendents of
committed T cell progenitors. This caveat also applies to
in vitro experiments in which Notch1 signaling is compromised
in progenitor populations from bone marrow or fetal liver.
This issue has now been addressed with the T cell-biased Cre
deleter. Genotyping of large numbers of single thymic B cells in
Notch1fl/flCpa3Cre mice has now directly demonstrated that
a major fraction of thymic B cells have a Notch1 genotype incon-
sistent with a model of Notch-dependent T-to-B cell conversion.
In keeping with low frequencies of Notch1 deletion in CLPs and
in immature and mature bone marrow B cells, the CD19hi thymic
B cells were not quantitatively Notch1 deleted. Because these
cells do not share a precursor-product relationship with
Notch1-deleted T cell progenitors, the effect of Notch1 on these
cells is non-cell autonomous, which we refer to as cell-extrinsic.
It is likely that these B cells develop in the bone marrow before
migrating into the thymus. Nevertheless, we noted the strongest
increment in absolute numbers in these CD19hi B cells in the
Notch1fl/flCpa3Cre thymus. One could argue that the major effect
of Notch1 deletion in pro-T cells in vivo is on the cell-extrinsic
pathway rather than on fate conversion. This notion may be rele-
vant for studies into the molecular basis of the role of Notch1 in
the T-B cell fate decision (Ikawa et al., 2006; Nie et al., 2008).
Evidence for a non-cell-autonomous effect of Notch deficiency
on thymic B cells had also been obtained in mice overexpressing
Lfng in thymocytes, which blocked T cell development and
promoted thymic B cells (Koch et al., 2001). In chimeric experi-
ments, thymic B cells arose not only from Lfng-transgenic
progenitors, but instead predominantly from nontransgenic
progenitors, suggesting a non-cell-autonomous mechanism
(Koch et al., 2001). Withdrawal of Notch ligands in the thymus
via Lfng-transgenic thymocytes has been proposed as a mecha-
nism to fit these data into the fate-conversion model (Visan et al.,
2006), but large numbers of non-Lfng-transgenic B cells more
likely correspond to the non-Notch1-deleted B cells that arise
in the cell-extrinsic pathway.
The non-cell-autonomous pathway to thymic B cells could
take advantage of available free niches in the thymus. This space
has been deserted because T cell development requires contin-76 Immunity 30, 67–79, January 16, 2009 ª2009 Elsevier Inc.uous Notch signaling (Garbe et al., 2006; Sambandam et al.,
2005; Schmitt et al., 2004). Thymic B cell expansion has been
noted in some, but not all, mutants affected by very early
blockade of T cell development (Wilson et al., 2001). Therefore,
deserted stromal niches may not fully explain the excessive B
cells in the Notch-deficient thymus. An alternative explanation
could be that the Notch-Delta signaling axis is a sensor for
contact between thymocytes and thymus epithelium. Dll4 is
strongly expressed in TECs, and Dll4-expressing TECs may
receive signals from Notch1-expressing thymocytes, directly
via Dll4 or indirectly via other receptors, and this could maintain
‘‘stromal conditions’’ fostering T cell development. In the
absence of Notch-Delta wiring, the thymus microenvironment
may become more permissive for B cells.
In contrast to this newly recognized cell-extrinsic pathway,
Notch1 was quantitatively deleted in the vast majority of
CD19lo B cells in Notch1fl/flCpa3Cre thymi. Consistent with this
notion, RFP-labeling frequencies were also higher in CD19lo B
cells compared to those in CD19hi B cells in Notch1fl/flCpa3Cre
RFP thymi (data not shown). However, RFP-labeling frequencies
did not reach the Notch1-deletion frequencies, indicating that
Cpa3Cre acted more efficiently on the Notch1fl allele than on
the ROSA26-RFP reporter allele. We thus consider the Notch1
genotype as the most direct molecular evidence for fate conver-
sion of Notch1-deleted pro-T cells to thymic B cells and, hence,
the cell-intrinsic pathway. TCR rearrangements were a clear
molecular marker of the ‘‘T cell lineage past’’ of fate-converted
B cells. High frequencies (>90%) of Cre activity were only found
in T cells, not in any of the B cell populations in bone marrow,
spleen, peritoneal cavity, or blood of Cpa3Cre mice, which can
only be explained by preferential labeling of the T cell lineage
after the T-B cell bifurcation. Interestingly, the Notch1-deletion
frequency was 90% already in the earliest thymic progenitors,
raising the possibility that the deletion occurred prior to thymus
homing.
It is conceivable that, in the normal thymus, not all pro-T cells
receive adequate Notch1 signaling, and, occasionally, limiting
Notch1 signaling may result in T-to-B cell conversion, as forced
here by deletion ofNotch1 in pro-T cells. It is an open question as
to whether this is accidental or useful. CD19lo thymic B cells may
be viewed as products of transdifferentiation (Xie and Orkin,
2007) from T cell to B cell, and they may represent a reciprocal
case of the remarkable B-to-T cell plasticity known from Pax5-
deficient pre-B cells (Rolink et al., 1999) and even from mature
B cells (Cobaleda et al., 2007). Despite their bona fide precursor
phenotype, CD19lo thymic B cells from Notch1fl/flCpa3Cre mice
may not be very efficient, fully normal B cell precursors. In adop-
tive-transfer experiments, CD19lo thymic B cells from Notch1fl/fl
Cpa3Cre mice gave rise to mature B cells only poorly when
compared to CD19lo pre-B cells from the bone marrow (data
not shown). It remains to be determined whether T-to-B cell con-
verted thymic B cells have fully implemented the molecular
circuitry (Rothenberg, 2007) of their newly adopted B cell lineage
fate.
There is little information on the physiologically relevant Notch
ligands in the thymus. Ectopic expression of Dll1 or Dll4 on
stromal cells can drive T cell development in vitro (Besseyrias
et al., 2007; Schmitt and Zuniga-Pflucker, 2002). As determined
on the basis of RT-PCR, several Notch ligands are expressed in
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expression in the thymus is controversial (Heinzel et al., 2007;
Schmitt et al., 2004). We have analyzed the expression of Dll1
and Dll4 by using knockin reporter mice. As determined on the
basis of LacZ staining, Dll1 expression is thymus blood vessel-
associated rather than epithelial. In contrast, theDll4LacZ knockin
reporter allele (Gale et al., 2004) showed very strong and ubiqui-
tous expression of Dll4 in the entire thymus. This expression
pattern is consistent with in situ hybridization data (Heinzel
et al., 2007). Dll1-deficient TECs did not show any defects in
support of T cell development, which is in agreement with condi-
tional deletion of Dll1 (Hozumi et al., 2004). Regarding the
function of Dll4 in vivo, we reached a limitation of the nude-
complementation assay. Presumably owing to the massive
requirement for Dll4 expression in vasculogenesis (Duarte
et al., 2004; Gale et al., 2004), we could not derive surviving
pups after injection of Dll4/ ES cells into 285 Foxn1nu/nu blas-
tocysts, transferred into 24 foster mothers. This is reminiscent
of the very low number of viable Dll4+/ mice (3 out of >300
offspring) derived from chimeric founders (Gale et al., 2004),
and it suggests thatDll4/ ES cells may be ‘‘toxic’’ during devel-
opment even in the presence of blastocyst-derived Dll4+/+ cells.
Despite these hurdles, we obtained two informative Dll4/
thymi. Unlike the cystic nude thymus, Dll4/ thymi had a
three-dimensional structure composed of cytokeratin+MHC
class II+ TECs, but Dll4/ thymi could not support T cell devel-
opment. In contrast to adult thymi lacking Notch1, B220+ B cells
were also rare. It remains to be determined whether this differ-
ence is related to newborn versus adult age. Although we cannot
rule out the possibility that Dll4 deficiency in other organs
contributed indirectly to the observed phenotype in these
chimeras, these experiments show (1) that Dll4 is very strongly
expressed in TECs throughout the thymus and (2) that thymus
development beyond the nude block is permissive in the
absence of Dll4 expression in TECs, and they suggest (3) that
Dll4 is essential for T cell development in vivo.
In summary, this work has shown that Notch1 expression
constrains latent potential of pro-T cells toward DC and B cell
lineages in the thymus. Moreover, caution may be warranted in
the interpretation of Notch-deletion experiments that lead to
the appearance of unusual cell types because only complex
genetic and cellular separation may reveal whether such
phenomena indeed reflect Notch-dependent fate conversion or
represent passenger cells that take advantage of the Notch
block in another lineage.
EXPERIMENTAL PROCEDURES
Mice
Mice bearing a conditional (floxed) Notch1 allele (Radtke et al., 1999) and
C57BL/6-Gt(ROSA)26Sortm1Hjf reporter mice expressing tandem-dimer RFP
in a Cre-dependent manner (Luche et al., 2007) have been described. The
Cpa3 locus was targeted in ES cells for inserting Cre into the first exon of
the Cpa3 gene (Supplemental Data), and targeted ES cells were used for
generating Cpa3Cre mice (to be designated Cpa3tm3Hrr). Dll1LacZ and Dll4LacZ
null alleles have been described (Gale et al., 2004; Hrabe de Angelis et al.,
1997). Dll1/ ES cells were derived from blastocysts obtained from inter-
crosses of Dll1+/ mice. Nude blastocyst complementation was done by
injecting Dll1/ or Dll4/ (Gale et al., 2004) ES cells into ‘‘Black-nude’’
(Taconic), or ‘‘Swiss-nude’’ (Charles River) blastocysts as described (Muller
et al., 2005).Flow Cytometry and Histology
Antibodies used are listed in the Supplemental Data. Cells were stained for flow
cytometry as described (Rodewald et al., 1997) and sorted or analyzed on FACS
Aria or CantoII instruments (BD Bioscience), respectively. For histology, whole
E18.5 or newborn pups were killed, placed in OCT, and snap frozen in liquid
nitrogen. Transversal sections of 5 mm were cut, acetone fixed, and stored at
70C. Thymi were removed and snap frozen in OCT on dry ice. 5 mm cryosec-
tions were treated as above and further analyzed by immunofluorescence or for
b-galactosidase histochemistry (Supplemental Data). For DC analysis, thymus
and spleen were digested as described in the Supplemental Data, and the
released DCs were analyzed by flow cytometry as indicated in Figure 5.
RT-PCR
RNA was prepared with RNAzol B (WAK-Chemie) followed by chloroform
extraction and RNA precipitation. Complimentary DNA (cDNA) was generated
with the SuperScript First Strand Synthesis System (Invitrogen). RT-PCR
conditions and oligonucleotides used to amplify Cpa3 and Actb are stated in
the Supplemental Data.
Notch1 Genotyping of Single Cells
Cells were sorted with the single-cell sorting mode (FACS Aria) and directly
deposited at one cell per well into PCR plates containing 25 ml 13 PCR buffer
(buffer 1 of the Expand Long Template PCR System, Roche) with 0.5mg/ml
proteinase K (Invitrogen). Cells were digested by proteinase K at 50C for
1 hr, and the enzyme was inactivated at 95C for 10 min. The genotype of
single cells was analyzed by nested PCR. PCR conditions and oligonucleo-
tides are given in the Supplemental Data.
Analysis of TCR Rearrangements
B cells were sorted as CD4CD8CD19loB220lo or CD4CD8CD19hiB220hi
cells from bone marrow or thymus, and DP thymocytes were sorted as
CD4+CD8+ cells from thymus.For avoiding possible contamination from thymo-
cytes, B cells were double sorted, and dead cells were excluded via Sytox blue
(Invitrogen). No thymocytes were detectable upon reanalysis of sorted B cells.
In the second sort, 200 cells were deposited into 25 ml 13 PCR buffer and
digested as described above for single-cell PCR. PCR analyses for TCR Db1
to Jb1 and TCR Db2 to Jb2 rearrangements were done as described in the
Supplemental Data or as reported earlier (Rodewald et al., 1997), respectively.
Statistical Analysis
Unless stated otherwise, average data are expressed as mean ± one standard
deviation. p values were calculated with the Mann-Whitney-test, and p < 0.05
was considered significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Results, Supplemental Experi-
mental Procedures, and three figures and can be found with this article online
at http://www.immunity.com/supplemental/S1074-7613(08)00542-6.
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